Enhancing Renal Graft Function During Donor Anesthesia

Launched by NAZMY EDWARD SEIF · Dec 17, 2018

Keywords

ClinConnect Summary

This clinical trial is studying how to improve the function of a transplanted kidney during surgery. It focuses on comparing three different methods: using a substance called Mannitol, a medication called Dopamine, and making sure patients are well-hydrated. The goal is to find out which method helps the new kidney work better right after the transplant.

To participate in this trial, you need to have end-stage renal disease and be scheduled for a living-donor kidney transplant. Unfortunately, people with severe heart or liver problems, or those with certain blood disorders, cannot take part. If you join the study, you will receive one of the three treatments during your surgery, and researchers will monitor how well your new kidney performs afterward. This research is important because it could lead to better outcomes for kidney transplant patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • end-stage renal disease, for living-donor kidney transplantation
• Exclusion Criteria:
• • severe cardiac or hepatic dysfunction
• • coagulopathy